COPD Trial, Recruiting NCT06726590 Sponsor: Texas A&M University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06726590
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently taking five or more medications, including prescription drugs, over-the-counter medicines, supplements, natural health products, cannabis products, or recreational drugs
  • People who are taking blood pressure or depression medications, even if the total number of medications is fewer than five
  • People who are able to understand the study and agree to take part
  • People who are willing to provide blood, urine, and cheek swab samples
  • People who are able to complete detailed questionnaires, including regular check-ins about medication side effects, memory-related tests, and quality of life questions
  • People who are comfortable having their health records and any changes in their health followed for five years, with that information shared with researchers in a way that does not identify them personally
  • People of any gender
  • People aged 18 years or older

Who may not be able to join:

  • People who are currently enrolled in hospice care
  • People who decline to take part or are unwilling to interact with study staff or share their health information
  • People who have a diagnosis of Alzheimer's disease or a related form of dementia recorded in their medical records
  • People who are unable or unwilling to give consent to participate
  • People who are not able to speak and understand English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (713) 677-7440

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Texas A&M University
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 November 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency and nature of ADRs on the Naranjo Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov